AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MEDICAL
Barr buys rival for $589 million
The drug maker will buy Duramed Pharmaceuticals to raise sales of its line of oral contraceptives and hormone products for women. Barr Labs will exchange one of its shares for every 3.9032 of Duramed. That values Duramed at $17.73 a share. Duramed closed at 17.89, up 0.99. Barr sees combined sales of about $700 million in fiscal 2002. Barr's 2000 sales were about $440 million; Duramed's were $83.5 million. Barr shares fell 2.24 to 69.20.
Dr. Reddy drugs get tentative OK
The Indian drug maker got tentative approval from the U.S. Food and Drug Administration to market generic forms of Eli Lilly's antidepressant Prozac and AstraZeneca's ulcer drug Prilosec. Dr. Reddy believes it has first-to-file status for both, giving it six-month exclusivity. Analysts say the opportunity is worth $30 million to $40 million. Dr. Reddy has risen more than 84% since its April initial public offering. It will market fluoxetine, the generic form of Prozac, through Pharmaceutical Resources.
Amgen said ...